Search company, investor...
Search

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

it-omics.com

Founded Year

2001

Stage

Acquired | Acquired

Total Raised

$300K

About IT Omics

Provider of scalable systems that collect, sort, analyze and extract genomics knowledge. The company provides the expertise required to develop in-silico tools to allow data to flow seamlessly across the drug discovery process. The company's core business consists of data-mining science and algorithms, associated with a deep understanding of biological objects, in order to support the drug discovery process by turning genomics data into pharmaceutical knowledge.

IT Omics Headquarters Location

885 avenue Eugene Avinee Parc Eurasante

Loos, 59120,

France

33 3 20 16 40 50

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

  • When was IT Omics founded?

    IT Omics was founded in 2001.

  • Where is IT Omics's headquarters?

    IT Omics's headquarters is located at 885 avenue Eugene Avinee, Loos.

  • What is IT Omics's latest funding round?

    IT Omics's latest funding round is Acquired.

  • How much did IT Omics raise?

    IT Omics raised a total of $300K.

  • Who are the investors of IT Omics?

    Investors of IT Omics include Genfit, Seventure Partners and Finorpa.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.